1995
DOI: 10.1007/s004310050365
|View full text |Cite
|
Sign up to set email alerts
|

Ketamine and strychnine treatment of an infant with nonketotic hyperglycinaemia

Abstract: Ketamine in combination with strychnine may be beneficial in non-ketotic hyperglycinaemia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
2
0
1

Year Published

1998
1998
2004
2004

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
2
0
1
Order By: Relevance
“…[6][7][8] Others have used dextromethorphan, ketamine or strychnine as non-competitive antagonists of one of the glycine receptors in the CNS. 9,10 Although these case reports support the use of such strategies, the evidence is anecdotal only and none have been consistently effective. 4 Other therapies are aimed at symptom control, in particular seizure management and currently advocated anticonvulsants include carbemazepine, lamotrigine and topiramate.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…[6][7][8] Others have used dextromethorphan, ketamine or strychnine as non-competitive antagonists of one of the glycine receptors in the CNS. 9,10 Although these case reports support the use of such strategies, the evidence is anecdotal only and none have been consistently effective. 4 Other therapies are aimed at symptom control, in particular seizure management and currently advocated anticonvulsants include carbemazepine, lamotrigine and topiramate.…”
Section: Discussionmentioning
confidence: 98%
“…Most therapies have been aimed at decreasing the glycine load in the CNS by reducing dietary glycine intake and by conjugating glycine to benzoate or salicylate, in a mechanism similar to that employed for hyperammonaemia 6−8 . Others have used dextromethorphan, ketamine or strychnine as non‐competitive antagonists of one of the glycine receptors in the CNS 9,10 . Although these case reports support the use of such strategies, the evidence is anecdotal only and none have been consistently effective 4 .…”
Section: Discussionmentioning
confidence: 99%
“…Ketamin ist ein nichtkompetitiver N-Methyl-D-Aspartat-Rezeptor-Antagonist, dessen praktische Bedeutung durch pharmakokinetische Besonderheiten limitiert ist, aber bei therapierefraktären zerebralen Anfällen in Erwä-gung gezogen werden kann [18,27]. Auch Benzodiazepine wie Diazepam, die die GABAerge Inhibition verstär-ken und möglicherweise auch mit der glutamatergen Transmission interferieren [18], werden eingesetzt [9].…”
Section: Diskussionunclassified